Metagenomic sequencing reveals altered gut microbial compositions and gene functions in patients with non-segmental vitiligoOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This study used metagenomic sequencing to characterize the gut microbiota of patients with non-segmental vitiligo. Researchers examined microbial community composition, diversity, and gene functions using bioinformatic analysis. They also predicted gut metabolic modules with the KEGG and MetaCyc databases to identify functional differences linked to the disease.
Who was studied?
The study enrolled 25 patients with non-segmental vitiligo and 25 matched healthy controls. All 50 participants underwent metagenomic sequencing of their gut microbiota for comparison between the two groups.
What were the most important findings?
Alpha diversity of the gut microbiome was significantly reduced in vitiligo patients compared with healthy controls. At the species level, Staphylococcus thermophiles was decreased while Bacteroides fragilis was increased in patients with vitiligo. LEfSe analysis identified additional microbial markers distinguishing vitiligo patients, including Lachnospiraceae_bacterium_BX3, Massilioclostridium_coli, and TM7_phylum_sp_oral_taxon_348, alongside Bacteroides_fragilis.
What are the greatest implications of this study?
These findings support a link between altered gut microbial composition and non-segmental vitiligo, reinforcing gut dysbiosis as a feature of the disease. The reduced diversity and specific species shifts, particularly the increase in Bacteroides fragilis, may serve as microbial markers for further investigation. Characterizing associated gene functions and metabolic modules could help clarify mechanisms connecting gut microbiota to vitiligo pathogenesis.